Medscan sold a stake in KDL to pay off billions of dollars in debt and avoid default.
Against the backdrop of an ongoing wave of defaults in the Russian bond market, Medscan continues to draw financing to cover its debt obligations. First, the clinic chain hastily announced a new issue of bonds and digital financial instruments for ₽10.5 billion, and has now begun to dispose of stakes in key assets.
The first to be sold was 49% of the shares of the KDL laboratory chain. According to the clinic chain, funds from the deal will be used, among other things, to pay off current debt obligations. However, selling a stake in the property will not restore the financial stability of Medscan, whose net debt has grown to ₽21.5 billion. The sale will only temporarily revive the company's negative liquidity, since after the transaction part of the income will go to the new shareholder.